Trial
NCT01312493
Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
Amgen
Condition
Head and Neck Cancer
Intervention
Panitumumab
Why stopped
Funding source was terminated before enrollment of first subject
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-08-28